Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: Involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1045-1052

  Crema, Francesca ^a   Modini, Chiara ^a   Croci, Tiziano ^a   Langlois, Michel ^a,b   De Ponti, Fabrizio ^a,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Dept of Int Med and Therapeutics   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [3 HYDROXYPIPERIDINO]ETHYL 4 AMINO 5 CHLORO 2 METHOXYBENZOATE; 2 PIPERIDINOETHYL 4 AMINO 5 CHLORO 2 METHOXYBENZOATE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (1 PIPERIDINYL)ETHYL ESTER; 5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; ATROPINE; CISAPRIDE; PROKINETIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DOG; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; DUODENUM MOTILITY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; JEJUNUM; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TACHYCARDIA;

AMINOBENZOIC ACIDS; ANIMALS; ATROPINE; CISAPRIDE; DOGS; DUODENUM; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART RATE; JEJUNUM; MYOELECTRIC COMPLEX, MIGRATING; PIPERIDINES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0032982422     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bedford TA and Rowbotham DJ (1996) Cisapride. Drug interactions of clinical significance. Drug Safety 15:167-175.
2. 4 receptor cloned form human atrium. FEBS Lett 412:465-474.
3. Carlsson L, Amos GJ, Andersson B, Drews L, Duker G and Wadstedt G (1997) Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: Implications for proarrhythmic potential? J Pharmacol Exp Ther 282:220-227.
4. Clayton NM and Gale JD (1996) 5-HT4 receptors are not involved in the control of small intestinal transit in the fasted conscious rat. Neurogastroenterol Motil 8:1-8.
5. Coremans G, Janssens J, Vantrappen G, Chaussade S and Ceccatelli P (1988) Cisapride stimulates propulsive motility patterns in human jejunum. Dig Dis Sci 33:1512-1519.
6. De Ponti F and Malagelada J-R (1998) Functional gut disorders: From motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther 80:49-88.
7. De Ponti F, D'Angelo L, Frigo GM and Crema A (1989) Inhibitory effects of calcium channel blockers on intestinal motility in the dog. Eur J Pharmacol 168:133-144.
8. De Ponti F, Einaudi A, Cosentino M, D'Angelo L, Lecchini S, Frigo GM and Crema A (1993) Differential effects of antimuscarinic agents on intestinal motility in the conscious dog. J Pharmacol Exp Ther 264:789-794.
9. Drolet B, Khalifa M, Daleau P, Hamelin BA and Turgeon J (1998) Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 97: 204-210.
10. Edelbroek M, Schuurkes J, De Ridder W, Horowitz M, Dent J and Akkermans L (1995) Effect of cisapride on myoelectrical and motor responses of antropyloroduodenal region during intraduodenal lipid and antral tachygastria in conscious dog. Dig Dis Sci 40:901-911.
11. Gale JD, Green A, Darton J, Sargent RS, Clayton NM and Bunce KT (1994a) GR125487: A5-HT4 receptor antagonist with a long duration of action in vivo. Br J Pharmacol 113:119P.
12. Gale JD, Grossman CJ, Darton J, Bunce KT, Whitehead JWF, Knight J, Parkhouse TJ, Oxford AW and Humphrey PPA (1994b) GR125487: A selective and high affinity 5-HT4 receptor antagonist. Br J Pharmacol 113:120P.
13. Graf S and Sarna SK (1996) 5-HT-induced jejunal motor activity: Enteric locus of action and receptor subtypes. Am J Physiol 270:G992-G1000.
14. 4 receptor mechanism. J Pharmacol Exp Ther 264:240-248.
15. 4 receptor antagonist, GR125487, on gastrointestinal motility in conscious dogs. Gastroenterology 112:741.
16. Hasler AH and Washabau RJ (1997) Cisapride stimulates contraction of idiopathic megacolonic smooth muscle in cats. J Vet Intern Med 11:313-318.
17. Hasler WL, Heldsinger A and Owyang C (1991) Cisapride acts on muscarinic (glandular M2) receptors to induce contraction of isolated gastric myocytes: Mediation via a calcium-phosphoinositide pathway. J Pharmacol Exp Ther 259:1294-1300.
18. 4 receptors. FASEB J 10:1398-1407.
19. 2-adrenoceptors in human atrium: Functional implications. Naunyn-Schmiedeberg's Arch Pharmacol 353:592-595.
20. 4 receptors in human atrium: Facilitation by chronic β-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch Pharmacol 349:331-337.
21. Kii Y and Ito T (1997) Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol 29:670-675.
22. 4 receptors coupled to distinct signaling pathways in human intestinal muscle cells. Gastroenterology 109:1791-1800.
23. 4 receptor agonist with nanomolar affinity. Bioorg Med Chem Lett 4:1433-1436.
24. 4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism. Eur J Clin Pharmacol 53: 479-480.
25. Michiels M, Monbaliu J, Hendriks R, Geerts R, Woestenborghs R and Heykants J (1987) Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog. Arzneim-Forsch/Drug Res 37:1159-1167.
26. + channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol 273:H2534-H2538.
27. Onat F, Yegen B, Berkman K and Oktay S (1994) The hypotensive effect of cisapride in the rat. Gen Pharmacol 25:1253-1256.
28. Orihata M and Sarna SK (1994) Contractile mechanisms of action of gastroprokinetic agents: Cisapride, metoclopramide, and domperidone. Am J Physiol 266: G665-G676.
29. Puisieux FL, Adamantidis MM, Dumotier BM and Dupuis BA (1996) Cisapride-induced prolongation of cardiac action potential and early after depolarizations in rabbit Purkinje fibres. Br J Pharmacol 117:1377-1379.
30. Rampe D, Roy ML, Dennis A and Brown AM (1997) A mechanism for the proarrhythmic effects of cisapride (Propulsid): High affinity of the human cardiac potassium channel HERG. FEBS Lett 417:28-32.
31. Saxena PR and Villalón CM (1991) 5-Hydroxytryptamine: A chameleon in the heart. Trends Pharmacol Sci 12:223-227.
32. Schemann M and Ehrlein HJ (1986) 5-Hydroxytryptophan and cisapride stimulate propulsive jejunal motility and transit of chyme in dogs. Digestion 34:229-235.
33. Summers RW and Flatt AJ (1988) A comparative study of the effects of four motorstimulating agents on canine jejunal spike bursts. The use of a computer program to analyze spike burst spread. Scand J Gastroenterol 23:1173-1181.
34. Tallarida RJ and Murray RB (1987) Manual of Pharmacologic Calculations with Computer Programs, 2nd ed., Springer, New York.
35. Tonini M, Messori E, Franceschetti GP, Rizzi CA, Castoldi AF, Coccini T and Candura SM (1994) Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle. Br J Pharmacol 113:1-2.
36. Volmer PA (1996) Cisapride toxicosis in dogs. Vet Human Toxicol 38:118-120.
37. Wager E, Tooley PJH, Pearce GL, Wilton LV and Mann RD (1997) A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study. Eur J Clin Pharmacol 52:87-94.
38. Wechsung E and Houvenaghel A (1998) Effect of cisapride on myoelectrical activity of the gastrointestinal tract in the conscious miniature pig. J Vet Med A 45:63-68.
39. Wysowski DK and Bacsanyi J (1996) Cisapride and fatal arrhythmia. N Engl J Med 335:290-291.
40. 4 receptors. J Med Chem 40:608-621.